Clinical Trial Update: Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating combined pneumococcal conjugate and polysaccharide vaccination in adults with inflammatory rheumatic diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Snippet

Sponsor: Region Skane | Conditions: Rheumatoid Arthritis, Systemic Lupus | Phase 4 | Status: COMPLETED